Showing results (441-450 of 494) with videos related to

Sort By:
Pageof 50
Molecular Genetics and Metabolism|February 23, 2016
Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VIHsiang-Yu Lin, Chih-Kuang Chuang, Ming-Ren Chen, et al.
Journal of Ethnopharmacology|September 14, 2016
Urine metabolomics study on the liver injury in rats induced by raw and processed Polygonum multiflorum integrated with pattern recognition and pathways analysisCong-En Zhang, Ming Niu, Qi Li, et al.
Journal of Inherited Metabolic Disease|October 7, 2010
Enzyme replacement therapy for mucopolysaccharidosis VI--experience in TaiwanHsiang-Yu Lin, Ming-Ren Chen, Chih-Kuang Chuang, et al.
American Journal of Medical Genetics. Part A|August 3, 2018
Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year periodHsiang-Yu Lin, Chih-Kuang Chuang, Chung-Lin Lee, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 12, 2014
Detecting multiple lysosomal storage diseases by tandem mass spectrometry--a national newborn screening program in TaiwanHsuan-Chieh Liao, Chuan-Chi Chiang, Dau-Ming Niu, et al.
Journal of Human Genetics|January 13, 2012
Mutation spectrum of and founder effects affecting the PTS gene in East Asian populationsYen-Hui Chiu, Ying-Chen Chang, Yu-Hsin Chang, et al.
Journal of Human Genetics|December 8, 2017
Improvement in the sensitivity of newborn screening for Fabry disease among females through the use of a high-throughput and cost-effective method, DNA mass spectrometryYung-Hsiu Lu, Po-Hsun Huang, Li-Yun Wang, et al.
Molecular Genetics and Metabolism Reports|June 28, 2018
Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screeningNaoaki Shibata, Yuki Hasegawa, Kenji Yamada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 23, 2020
Metabolomic profiles of breath odor compounds for prognostic prediction in patients with acute-on-chronic liver failure: A pilot studyJing Jing, Xiu-Xiu Sang, Shao-Li You, et al.
Journal of the Chinese Medical Association : JCMA|January 7, 2014
Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfaHsiang-Yu Lin, Yu-Hsiu Huang, Hsuan-Chieh Liao, et al.
Pageof 50